Skip to main content
Clinical Trials/CTRI/2021/06/034030
CTRI/2021/06/034030
Not yet recruiting
未知

A preclinical and clinical study to determine the efficacy of Neelkanthi Churna in management of Madhumeha w.s.r to Type 2 Diabetes Mellitus

Principal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Principal
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Principal

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients of either sex aged between 20\-70yrs.
  • 2\) Newly diagnosed patients of Type 2 Diabetes Mellitus having glycosylated Hb (HbA1C) between 6\.5% to 10%
  • 3\) Patients willing to participate in the trial.

Exclusion Criteria

  • Subject of Type\-1 DM or Type\-2 DM on insulin/OHAââ?¬•s other than Metformin/ any other medication for glucose control in the last 3 months
  • Subjects suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment.
  • Patients having major medical illness like cancer, concurrent infection like tuberculosis.
  • Patients with uncontrolled Hypertension.
  • Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.
  • Renal dysfunction (defined by eGFR \< 60ml/min calculated by MDRD calculator)
  • Subjects who have completed participation in any other clinical trial during the past 3 months.
  • Any other condition which the investigator thinks may compromise the safety of subject.
  • Subjects with Haemoglobin percentage \< 9gm% for males and \< 8gm%for females.

Outcomes

Primary Outcomes

Not specified

Similar Trials